TrialInternational journal of clinical oncology2020

Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.

Wen Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.